Business Development

Business Development

Specialty pharmaceutical companies can create the most value by establishing capabilities across the four primary segments that comprise the industry. Cumberland Pharmaceuticals has established capabilities in all four segments of this value chain:

Cumberland's primary business development objectives include acquiring rights to marketed and late-stage branded, prescription pharmaceutical products in the following medical specialties:

Critical Care
Emergency Medicine
Gastroenterology

Cumberland Pharmaceuticals pursues rights to additional products through acquisitions, licenses and promotion arrangements. If you are interested in divesting a product or partnering with Cumberland, or for more business development information, please contact:

Elizabeth Gerken
Director, Business Development
Cumberland Pharmaceuticals Inc.
2525 West End Avenue, Suite 950
Nashville, TN 37203
Tel: (615) 255-0068
development@cumberlandpharma.com